Advanced Medical Solutions Group plc

As of December 31, 2025, Advanced Medical Solutions Group plc carries a market capitalization of 47.18B, placing it among publicly traded companies globally. Its enterprise value stands at 53.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Advanced Medical Solutions Group plc's next confirmed earnings release is scheduled for March 17, 2027.

As of December 31, 2025, Advanced Medical Solutions Group plc has 216.40M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Advanced Medical Solutions Group plc maintains a current ratio of 2.79, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Advanced Medical Solutions Group plc's stock has gained approximately 25.33% over the past 52 weeks. The 50-day moving average sits at 281.65, while the 200-day moving average is 245.34.

As of December 31, 2025, Advanced Medical Solutions Group plc holds 1.80B in cash and equivalents against 8.15B in total debt, resulting in a net debt position of 5.05B. Total book value stands at 25.88B, with working capital of 8.94B providing operational flexibility.

Advanced Medical Solutions Group plc's most recent stock split took place on April 2, 2002 with a 383:387 split ratio.